Related Experiment Video
Updated: Mar 1, 2026

06:29
Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
2.8K
Consensus on Diagnostic Criteria of Idiopathic Orbital Inflammation Using a Modified Delphi Approach
Ilse Mombaerts1, Jurij R Bilyk2, Geoffrey E Rose3
1Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium.
JAMA Ophthalmology
|June 2, 2017
Summary
Establishing clear diagnostic criteria for idiopathic orbital inflammation (IOI) is crucial for accurate diagnosis and improved patient outcomes. This study defined consensus criteria for IOI, distinguishing it from other orbital conditions.
Area of Science:
- Ophthalmology
- Pathology
- Medical Diagnostics
Background:
- Current diagnosis of idiopathic orbital inflammation (IOI) lacks consistency, leading to misdiagnosis of orbital conditions, including cancer.
- Standardized diagnostic criteria are needed to improve the accuracy and reliability of IOI diagnosis.
Purpose of the Study:
- To establish a consensus-based set of diagnostic criteria for idiopathic orbital inflammation (IOI).
Main Methods:
- A 3-round modified Delphi process was employed with 35 international orbital experts.
- Experts evaluated and ranked potential diagnostic criteria for nonmyositic and myositic IOI subtypes using Likert scales.
- Consensus was reached on clinical, radiologic, and pathologic items for IOI diagnosis.
Main Results:
- Consensus was achieved on diagnostic criteria for both nonmyositic and myositic IOI subtypes.
- Key findings include the importance of surgical tissue biopsy for nonmyositic IOI and systemic corticosteroids for myositic IOI.
- A threshold of 30 IgG4-positive plasma cells per high-power field was agreed upon for IOI diagnosis.
Conclusions:
- An international expert panel has endorsed consensus diagnostic criteria for IOI.
- These criteria provide a framework for diagnosis, emphasizing exclusion and specific investigations like tissue biopsy.
- Further validation studies are necessary to implement these criteria into clinical guidelines for IOI management.

